Data Catalog

EBODAC

Communication strategy and tools for optimizing the impact of Ebola vaccination deployment

Keywords: IMI projects Infectious diseases Ebola and related diseases Vaccines Ebola+ Tools for predicting/monitoring efficacy

Start: 2014-12-01
Project website

EBiSC2

EBiSC2 - A sustainable European Bank for induced pluripotent Stem Cells

Keywords: IMI projects Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Biobanks Stem cells

Start: 2019-03-01
Project website

EPND

European Platform for Neurodegenerative Diseases

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease Tools for predicting/monitoring efficacy Biobanks Clinical networks Big data and knowledge management

Start: 2021-11-01
Project website

Keywords: IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Education and training Imaging

Start: 2017-10-01
Project website

IM2PACT

Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain

Keywords: IMI projects Diabetes & metabolic disorders Neurodegenerative diseases Alzheimer's disease Tools for predicting/monitoring efficacy Drug delivery

Start: 2019-01-01
Project website

IMI-PainCare

Improving the care of patients suffering from acute or chronic pain

Keywords: IMI projects Neurodegenerative diseases Pain Tools for predicting/monitoring efficacy Patient involvement in R&D Disease taxonomy Imaging

Start: 2018-04-01
Project website

IMMUCAN

Integrated immunoprofiling of large adaptive cancer patients cohorts

Keywords: IMI projects Cancer Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety

Start: 2019-03-01
Project website

Immune safety avatar: nonclinical mimicking of the i...

Certain treatments for cancers and autoimmune diseases work by altering the immune system. However, a major challenge for researchers is identifying potential efficacy and safety issues with these treatments early in drug development, before they are tested in humans. Part of the problem is that the tests used early in drug development do not reflect the full complexity of the human immune system. In addition, these tests tend to be based on a healthy immune system, which is different to the ...

Keywords: IMI projects Immunology Autoimmune diseases Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety